Clinical trial

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

NCT01591551

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-03-01

PhasePHASE4

Study timeline

Study start (unknown)2012-03-01Date precision: month

Registry last updated2014-01-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing-Remittingunresolved

Interventions

Natalizumab (Tysabri)DRUG

Sponsors & collaborators

Cornerstone Health Care, PAlead sponsor

Biogencollaborator

Mapped research locations

PortlandOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01591551 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.